Talk:QuikClot

Requested move 9 June 2020

 * The following is a closed discussion of a requested move. Please do not modify it. Subsequent comments should be made in a new section on the talk page. Editors desiring to contest the closing decision should consider a move review after discussing it on the closer's talk page. No further edits should be made to this discussion. 

The result of the move request was: Non-contested move buidhe 01:06, 19 June 2020 (UTC)

Hemostatic dressing → QuikClot – This page is called Hemostatic dressings yet it only talks about one brand; quikclot. There are a number of other brands, such as Celox, that are not mentioned. The article lacks scope for it’s title; zeolite and kaolin are used in quikclot dressings, however it does not discuss the far more widespread chitosan based hemostatic dressings used by quikclots competitors. If you look at the edit history you can see quikclots marketing team have been on the page (WP:CONFLICT). The page seems somewhat commercial, for example listing that quikclot is used by US military but failing to note that other brands are too. It starts by saying “Hemostatic dressings, such as QuikClot...”, however the only two sections on the article (history and mechanism) are very specific to quikclot and don’t cover the history of hemostatic dressings as a whole or the mechanisms of alternate brands. Clearly commercial, should be moved appropriately and possibly tanken down for COI

This page is only about one brand and does not cover the wider topic. As such, the page should be moved to the brand rather than pretending to cover a much wider topic.

See more;

https://www.jems.com/2008/02/29/use-hemostatic-dressings-civil/

https://jts.amedd.army.mil/assets/docs/cpgs/Prehospital_En_Route_CPGs/Tactical_Combat_Casualty_Care_Guidelines_01_Aug_2019.pdf

https://www.realfirstaid.co.uk/haemostatics Editor/123 09:48, 9 June 2020 (UTC)


 * The discussion above is closed. Please do not modify it. Subsequent comments should be made on the appropriate discussion page. No further edits should be made to this discussion.